After the dust settles and all the bad news is out... The techs seem to be lining up pretty well with the welcomed addition of a near-term catalyst in the form of Phase 2 trial results due out at the end of Sept.. Good news has the potential to send this stock higher... Any bad news... there's not much floor left, so seems to be a great risk/reward scenario at this point. Time will tell.